Chemoinformaics analysis of Zizyberanalic acid
| Molecular Weight | 452.679 | nRot | 3 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 27 |
| Exact Molecular Weight | 452.329 | nRing | 5 |
| Solubility: LogS | -5.641 | nHRing | 0 |
| Solubility: LogP | 6.453 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 81.8449 |
| nHD | 1 | BPOL | 45.8771 |
| QED | 0.368 |
| Synth | 5.081 |
| Natural Product Likeliness | 2.99 |
| NR-PPAR-gamma | 0.226 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -5.323 |
| MDCK | 0.0000148 |
| BBB | 0.125 |
| PPB | 0.857715 |
| VDSS | 0.605 |
| FU | 0.0963188 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.421 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.297 |
| CYP2c9-sub | 0.768 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.435 |
| CYP3a4-inh | 0.494 |
| CYP3a4-sub | 0.418 |
| CL | 1.909 |
| T12 | 0.147 |
| hERG | 0.032 |
| Ames | 0.009 |
| ROA | 0.241 |
| SkinSen | 0.881 |
| Carcinogencity | 0.414 |
| EI | 0.302 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.768 |
| Antiviral | Yes |
| Prediction | 0.511284 |